Stocks Health care MDWD
NASDAQ · Health careMediWound Ltd. (MDWD)
MediWound Ltd. reported revenue of $17M in fiscal 2025, down 16.1% from a year earlier. It posted a net loss of $23.9M. In fiscal 2025 capital spending exceeded operating cash flow by $21.6M. At December 31, 2025 it held $4.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 5, 2026.
What MediWound Ltd. does
MediWound Ltd. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker MDWD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $17M | -$23.9M | -$2.10 | -$21.6M |
| 2024 | $20.2M | -$30.2M | -$3.03 | -$19.9M |
| 2023 | $18.7M | -$6.7M | -$0.75 | -$16.9M |
| 2022 | $26.5M | -$19.6M | -$3.93 | -$12.4M |
| 2021 | $23.8M | -$13.6M | -$3.48 | -$9.4M |
| 2020 | $21.8M | -$9.2M | -$2.38 | -$7.8M |
Latest SEC filings
What MediWound Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 28, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- May 27, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 6, 2026
- April 2, 2026
- March 30, 2026
- March 5, 2026
- March 5, 2026Annual report (foreign issuer) 20-F · period to December 31, 2025
Questions about MDWD
What does MediWound Ltd. do?
MediWound Ltd. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker MDWD.
Is MediWound Ltd. profitable?
No. In fiscal 2025 it reported a net loss of $23.9M on revenue of $17M.
How much revenue does MediWound Ltd. make?
In fiscal 2025 MediWound Ltd. reported revenue of $17M. That is 16.1% less than a year earlier.
When did MediWound Ltd. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 5, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the insider trade from September 2, 2026.
Similar companies
Follow MDWD
Get an email when MediWound Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Follow MDWD: get an email when it filesWhere the numbers come from
Financial figures are the values MediWound Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.